Thesis Abstract

Abstract
The increasing challenge of antibiotic resistance has become a global health concern, necessitating the exploration of alternative therapeutic options. Bacteriophages, viruses that infect and kill bacteria, have emerged as a promising alternative to traditional antibiotics in the treatment of bacterial infections. This thesis investigates the potential use of bacteriophages as an alternative to antibiotics in treating bacterial infections. The study aims to evaluate the efficacy, safety, and feasibility of utilizing bacteriophages as therapeutic agents against bacterial pathogens. Chapter One provides an introduction to the research topic and outlines the background of the study, problem statement, objectives, limitations, scope, significance, structure of the thesis, and definition of key terms. The literature review in Chapter Two critically analyzes existing research on the use of bacteriophages as an alternative to antibiotics, highlighting the advantages and challenges associated with this approach. Chapter Three details the research methodology, including the selection of bacteriophages, bacterial strains, experimental design, and data collection methods. The methodology section also describes the procedures for bacteriophage isolation, characterization, and assessment of antibacterial activity. Furthermore, the ethical considerations and potential risks associated with bacteriophage therapy are discussed. In Chapter Four, the findings of the study are comprehensively analyzed and discussed. The results of bacteriophage efficacy against various bacterial strains, including multidrug-resistant pathogens, are presented and interpreted. The discussion also addresses the mechanisms of bacteriophage action, host range specificity, potential for phage resistance development, and the application of phage cocktails for enhanced therapeutic outcomes. Chapter Five provides a conclusion and summary of the thesis, highlighting the key findings, implications, and future research directions. The study concludes that bacteriophages hold significant promise as a viable alternative to antibiotics in the treatment of bacterial infections. However, further research is needed to optimize phage therapy protocols, address safety concerns, and overcome regulatory challenges to facilitate the clinical translation of bacteriophage-based treatments. In conclusion, this thesis contributes to the growing body of knowledge on bacteriophage therapy and its potential applications in combating antibiotic-resistant bacterial infections. By exploring the use of bacteriophages as an alternative to antibiotics, this study aims to advance the development of innovative and sustainable strategies for addressing the global threat of antibiotic resistance.

Thesis Overview